Effect of Muscle Relaxation Reversal on the Success Rate of Motor Evoked Potential Recording

NACompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

August 16, 2021

Primary Completion Date

August 30, 2022

Study Completion Date

August 30, 2022

Conditions
SugammadexMotor Evoked Potentials
Interventions
DRUG

Sugammadex

The muscle relaxant infusion will be discontinued and a bolus of sugammadex (2mg/kg) will be given while performing TceMEPs.

DRUG

Saline

The muscle relaxant infusion will be discontinued and 2ml saline will be infused, TceMEPs monitoring will be performed 5 minutes later.

Trial Locations (1)

100070

Beijing Tiantan Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT04608682 - Effect of Muscle Relaxation Reversal on the Success Rate of Motor Evoked Potential Recording | Biotech Hunter | Biotech Hunter